Pasar al contenido principal

CHAPERONAS, INHIBIDORES Y NUTRACEUTICOS BASADOS EN CARBOHIDRATOS PARA APLICACIONES BIOMEDICAS: DESORDENES DE DEPOSITO LISOSOMAL, CANCER Y ENFERMEDAD DE CROHN

SAF2013-44021-R

•
Nombre agencia financiadora Ministerio de Economía y Competitividad
Acrónimo agencia financiadora MINECO
Programa Programa Estatal de I+D+i Orientado a los Retos de la Sociedad
Convocatoria Proyectos I+D+i Retos de Investigación
Año convocatoria 2013
Plan Estatal 2013-2016 Plan Estatal de Investigación Científica y Técnica y de Innovación
Unidad de gestión Secretaría de Estado de Educación, Formación Profesional y Universidades
Centro beneficiario UNIVERSIDAD DE SEVILLA
Identificador persistente http://dx.doi.org/10.13039/501100003329

Resultados relacionados

Resultados totales (Incluyendo duplicados): 9
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Pharmacological Chaperones and Coenzyme Q10 Treatment Improves Mutant β-Glucocerebrosidase Activity and Mitochondrial Function in Neuronopathic Forms of Gaucher Disease

  • Mata, Mario de la
  • Cotán, David
  • Oropesa-Ávila, Manuel
  • Garrido-Maraver, Juan
  • Cordero, Mario D.
  • Villanueva-Paz, Marina
  • Delgado Pavón, Ana
  • Alcocer-Gómez, Elísabet
  • Lavera, I. de
  • Ybot, Patricia
  • Zaderenko, Paula
  • Ortiz-Mellet, Carmen
  • García Fernández, José Manuel
  • Sánchez-Alcázar, José Antonio
This work is licensed under a Creative Commons Attribution 4.0 International License., Gaucher disease (GD) is caused by mutations in the GBA1 gene, which encodes lysosomal β -glucocerebrosidase. Homozygosity for the L444P mutation in GBA1 is associated with high risk of neurological manifestations which are not improved by enzyme replacement therapy. Alternatively, pharmacological chaperones (PCs) capable of restoring the correct folding and trafficking of the mutant enzyme represent promising alternative therapies.Here, we report on how the L444P mutation affects mitochondrial function in primary fibroblast derived from GD patients. Mitochondrial dysfunction was associated with reduced mitochondrial membrane potential, increased reactive oxygen species (ROS), mitophagy activation and impaired autophagic flux. Both abnormalities, mitochondrial dysfunction and deficient β -glucocerebrosidase activity, were partially restored by supplementation with coenzyme Q10 (CoQ) or a L-idonojirimycin derivative, N-[N’-(4-adamantan-1-ylcarboxamidobutyl)thiocarbamoyl]-1,6-anhydro-L-idonojirimycin (NAdBTAIJ), and more markedly by the combination of both treatments. These data suggest that targeting both mitochondria function by CoQ and protein misfolding by PCs can be promising therapies in neurological forms of GD, This work was supported by the Spanish Ministerio de Sanidad (FIS PI13/00129 grant), the Spanish Ministerio de Economía y Competitividad (contract numbers SAF2013-44021-R and CTQ2010-15848), the Junta de Andalucía (Proyectos de Investigación de Excelencia CTS-5725 and FQM-1467), the Fondo Europeo de Desarrollo Regional (FEDER-Unión Europea), the Fondo Social Europeo (FSE), by AEPMI (Asociación de Enfermos de Patología Mitocondrial) and by Mehuer Foundation., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Glycomimetic-based pharmacological chaperones for lysosomal storage disorders: lessons from Gaucher, GM1-gangliosidosis and Fabry diseases

  • Sánchez-Fernández, Elena M.
  • García Fernández, José Manuel
  • Ortiz-Mellet, Carmen
Lysosomal storage disorders (LSDs) are often caused by mutations that destabilize native folding and impair the trafficking of enzymes, leading to premature endoplasmic reticulum (ER)-associated degradation, deficiencies of specific hydrolytic functions and aberrant storage of metabolites in the lysosomes. Enzyme replacement therapy (ERT) and substrate reduction therapy (SRT) are available for a few of these conditions, but most remain orphan. A main difficulty is that virtually all LSDs involve neurological decline and neither proteins nor the current SRT drugs can cross the blood–brain barrier. Twenty years ago a new therapeutic paradigm better suited for neuropathic LSDs was launched, namely pharmacological chaperone (PC) therapy. PCs are small molecules capable of binding to the mutant protein at the ER, inducing proper folding, restoring trafficking and increasing enzyme activity and substrate processing in the lysosome. In many LSDs the mutated protein is a glycosidase and the accumulated substrate is an oligo- or polysaccharide or a glycoconjugate, e.g. a glycosphingolipid. Although it might appear counterintuitive, substrate analogues (glycomimetics) behaving as competitive glycosidase inhibitors are good candidates to perform PC tasks. The advancements in the knowledge of the molecular basis of LSDs, including enzyme structures, binding modes, trafficking pathways and substrate processing mechanisms, have been put forward to optimize PC selectivity and efficacy. Moreover, the chemical versatility of glycomimetics and the variety of structures at hand allow simultaneous optimization of chaperone and pharmacokinetic properties. In this Feature Article we review the advancements made in this field in the last few years and the future outlook through the lessons taught by three archetypical LSDs: Gaucher disease, GM1-gangliosidosis and Fabry disease., The Spanish Ministerio de Economía y Competitividad (MINECO, contract numbers SAF2013-44021-R and CTQ2015-64425-C2-1-R), the Junta de Andalucía (contract number FQM-1467), and the European Union Seventh Framework Programme (FP7-People-2012-CIG), grant agreement number 333594 (to E. M. S. F., Marie Curie Reintegration Grant) are acknowledged. Cofinancing from the European Regional Development Funds (FEDER and FSE) is also thanked., We acknowledge support by the CSIC Open Access Publication Initiative through its Unit of Information Resources for Research (URICI)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Trehalose-based Janus cyclooligosaccharides: the ‘‘Click’’ synthesis and DNA-directed assembly into pH-sensitive transfectious nanoparticles

  • Jiménez Blanco, José L.
  • Ortega-Caballero, Fernando
  • Junquera, Elena
  • Mendicuti, Francisco
  • Tros de Ilarduya, Conchita
  • Ortiz-Mellet, Carmen
  • García Fernández, José Manuel
This article is licensed under a Creative Commons Attribution 3.0 Unported Licence.-- et al., The convergent preparation of Janus molecular nanoparticles by thiourea-‘‘clicking’’ of a,a0 -trehalose halves has been implemented; the strategy allows access to macrocyclic derivatives with seggregated cationic and lipophilic domains that in the presence of DNA undergo pH-dependent self-assembly into lamellar superstructures, as established by electrochemical, structural (SAXS), microscopical (TEM) and computational techniques, that mediate transfection in vitro and in vivo., We acknowledge support by the CSIC Open Access Publication Initiative through its Unit of Information Resources for Research (URICI)., The authors thank MINECO (contract numbers CTQ2012- 30821, SAF2013-44021-R, CTQ2015-64425-C2-1-R and CTQ2015-64425-C2-2-R), the Junta de Andalucía (contract number FQM2012-1467), University Complutense of Madrid (project no. UCMA05-33-010), the Government of Navarra (Department of Innovation and Industry, contract number IIQ14334.RI1), the University of Navarra Foundation (FUN), and the European Regional Development Funds (FEDER and FSE) for financial support., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Modulation of microglia polarization dynamics during diabetic retinopathy in db/db mice

  • Arroba, Ana I.
  • García-Ramírez, Marta
  • Cazzoni, Daniele
  • García Fernández, José Manuel
  • Valverde, Ángela M.
Retinal diseases linked to inflammation are often accompanied by macrophage/microglial cells activation. However, the dynamics between M1 (pro-inflammatory) and M2 (anti-inflammatory) polarization of microglia during diabetic retinopathy (DR) has not been investigated and it might be therapeutically useful. We assessed microglia polarization in retinas from db/db mice and human diabetic donors and also the microgliamediated anti-inflammatory effects of the bicyclic nojirimycin derivative (1R)-1-dodecylsulfinyl-5N,6Ooxomethylidenenojirimycin (R-DS-ONJ). Visual function in mice was evaluated by electroretinogram (ERG). Expression of pro- and anti-inflammatory markers in the retina was analyzed by immunofluorescence, Western-blot and quantitative real-time PCR. Lipopolysaccharide (LPS)-mediated polarization profile was studied in Bv.2 microglial cells in the absence or presence of anti-inflammatory cytokines (IL4/IL13) or R-DSONJ. At 5weeks of age, reduced ERG amplitude values of rod and mixed waves were detected in db/db compared to db/+ mice that correlated with elevated circulating endotoxemia and pro-inflammatory cytokines. At this early stage of DR, the marker of activated microglia Iba-1 co-localized with the M2 marker arginase-1 in the retina. Conversely, in retinas from 8 weeks old db/db mice Iba-1-colocalizedwith active caspase-1, a key component of the inflammasome, reflecting an opposite pattern of microglia polarization. Markers of activated microglia were detected in retinas of diabetic donors. Treatment of Bv.2 cells with LPS and IL4/IL13 or R-DS-ONJ switched the M1 response towards M2. In retinal explants from db/db mice, R-DS-ONJ induced a M2 response. In conclusion, the modulation of microglia polarization dynamics towards aM2 status at early stages of DR offers novel therapeutic interventions., This work was supported by grants from the Spanish Ministry of Economy and Competitivity: SAF2015-65267-R(MINECO/RETOS), SAF2012-35562 and SAF2013-44021-R, the Junta de Andalucía (FQM2012-1467), Comunidad de Madrid S2010/BMD-2423 and S2010/BMD2439, Instituto de Salud Carlos III Grant number PI13-02098, Centro de Investigación Biomédica en Red de Diabetes y Enfermedades Metabólicas Asociadas (CIBERdem, Instituto Carlos III, Spain), Red de Patología Ocular Prevalente y Crónica (OFTARED, Instituto de Salud Carlos III, Spain), European Union (EUROCONDOR (FP7 HEALTH.2011.2.4.3.1.), and the European Union Seventh Framework Programme (FP7-People-2012-CIG) grant agreement number 333594., Peer Reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Tuning of glyconanomaterial shape and size for selective bacterial cell agglutination

  • Cid Martín, J. J.
  • Assali, Mohyeddin
  • Fernández García, Elisabet
  • Valdivia, Victoria
  • Sánchez-Fernández, Elena M.
  • García Fernández, José Manuel
  • Wellinger, Ralf Erik
  • Fernández, I.
  • Khiar, Noureddine
Multivalent glycosystems are potential candidates for anti-adhesive therapy, a non-lethal approach against the ever increasing antibiotic resistance of pathogenic bacteria. In order to fine-tune the glyconanomaterial size and shape for selective bacterial cell agglutination, herein we report the synthesis of sugar-coated dynamic and polymeric 3D-micelles and 1D-carbon nanotubes. The reported shot-gun like synthetic approach is based on the ability of diacetylenic-based neoglycolipids to self-assemble into micelles in water and hierarchically self-assemble into hemimicelles on a single-walled carbon nanotube surface. The affinity of the nanosystems was preliminarily assessed by enzyme-linked lectin assay (ELLA) using the mannose-specific Concanavalin A lectin as a model receptor. Relative binding potency enhancements, compared to methyl ¿-d-mannopyranoside used as control, from 10- to 25- to 2340-folds in sugar molar basis were observed when passing from 3D dynamic micelles to static micelles, to 1D-mannose coated carbon nanotubes, respectively, indicative of a significant cluster glycoside effect. Importantly, these results were confirmed in vivo showing that the 1D-glyconanoring-coated carbon nanotubes efficiently and selectively regulate the agglutination and proliferation of the enterobacteria Escherichia coli type 1 fimbriae. These findings highlight the potential of sugar coated nano-materials as novel and effective tools in the control of bacterial pathogenesis., Financial support was provided by the Andalusian Ministry of Economy, Science and Innovation (P07-FQM-2774 to NK, P11-FQM-8046 to IF, FQM-1467 to JMGF, P08-CTS-04297, and P11-CTS-7962 to REW), the PAIDI Program from the Andalusian Government (FQM-313 to NK, FQM-102 to IF, BIO-026 to REW), the Spanish Ministry of Economy and Competitiveness (CTQ2013-49066-C2-1-R to NK and SAF2013-44021R to EMSF) and the European Union Seventh Framework Programme (FP7-People2012-CIG, grant agreement no. 333594 to EMSF). The European Regional Development Fund (FEDER) and the European Social Fund (ESF) are also acknowledged. MA was a recipient of a MAECAECID PhD fellowship. JJC was a recipient of a JAE-CSIC postdoctoral fellowship. EFG is a recipient of a fellowship from Junta de Andalucia., Peer Reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Influence of the configurational pattern of sp2-iminosugar pseudo N-, S-, O- and C-glycosides on their glycoside inhibitory and antitumor properties

  • Sánchez-Fernández, Elena M.
  • Gonçalves-Pereira, Rita
  • Rísquez-Cuadro, Rocio
  • Plata, Gabriela B.
  • Padrón, José M.
  • García Fernández, José Manuel
  • Ortiz Mellet, Carmen
The synthesis of a complete series of cyclic carbamate-type sp-iminosugar N-, S-, O- and C-octyl pseudoglycosides related to nojirimycin, mannojirimycin and galactonojirimycin, all having the α-pseudoanomeric configuration, is reported. The gem-diamine-type N-pseudoglycosides can be accessed directly from the corresponding reducing sp-imisosugar precursors by reaction with octylamine in methanol, whereas per-O-acetyl or 1-fluoro derivatives were used as pseudoglycosyl donors for the preparation of S-pseudoglycosides or O- and C-pseudoglycosides, respectively. Evaluation of their inhibitory properties against a panel of glycosidases evidenced selectivity profiles that strongly depend on the configurational pattern and the nature of the glycosidic linkage. On the contrary, the antiproliferative activity determined against a panel of tumor cell lines was largely independent of the relative orientation of the hydroxyl groups in the sp-iminosugar moiety. Indeed, sp-iminosugar representatives exhibiting significant growth inhibition potencies were identified in all three configurationally different types of compounds studied, namely α-d-gluco, α-d-manno and α-d-galacto glycoside analogs. Interestingly, none of the compounds affected viability and mortality of normal cells at the used concentrations. Altogether, the results strongly suggest that the anticancer activity of amphiphilic sp-iminosugar glycosides might be unrelated, or not solely related, to their glycosidase inhibitory activity., The Spanish Ministerio de Economía y Competitividad (MINECO, contract numbers SAF2013-44021-R, CTQ2012-31605), the Junta de Andalucía (contract number FQM-1467) and the European Union Seventh Framework Programme (FP7-People-2012-CIG), grant agreement number 333594 (to E.M.S.F., Marie Curie Reintegration Grant) are acknowledged. Cofinancing from the European Regional Development Funds (FEDER and FSE) is also thanked.info:eu-repo/grantAgreement/EC/FP7/333594
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Potent glycosidase inhibition with heterovalent fullerenes: unveiling the binding modes triggering multivalent inhibition

  • Abellán-Flos, M.
  • García Moreno, María Isabel
  • Ortiz-Mellet, Carmen
  • García Fernández, José Manuel
  • Nierengarten, J. F.
  • Vincent, Stéphane P.
Glycosidases are key enzymes in metabolism, pathogenic/antipathogenic mechanisms and normal cellular functions. Recently, a novel approach for glycosidase inhibition that conveys multivalent glycomimetic conjugates has emerged. Many questions regarding the mechanism(s) of multivalent enzyme inhibition remain unanswered. Herein we report the synthesis of a collection of novel homo- and heterovalent glyco(mimetic)-fullerenes purposely conceived for probing the contribution of non-catalytic pockets in glysosidases to the multivalent inhibitory effect. Their affinities towards selected glycosidases were compared with data from homovalent fullerene conjugates. An original competitive glycosidase–lectin binding assay demonstrated that the multivalent derivatives and the substrate compete for low affinity non-glycone binding sites of the enzyme, leading to inhibition by a “recognition and blockage” mechanism. Most notably, this work provides evidence for enzyme inhibition by multivalent glycosystems, which will likely have a strong impact in the glycosciences given the utmost relevance of multivalency in Nature., We thank the People Programme (Marie Curie Actions) of the European Union's Seventh Framework Programme FP7/2007‐2013/ under REA grant agreement no. 289033 and COST Action CM‐1102 MultiGlycoNano for the financial support. We also acknowledge financial support from the Spanish Ministerio de Economía y Competitividad (contract numbers SAF2013‐44021‐R and CTQ2015‐64425‐C2‐1‐R), the Junta de Andalucía (contract number FQM2012‐1467) and the European Regional Development Funds (FEDER and FSE).
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Fast and solvent free polymerization of carbohydrates induced by non-thermal atmospheric plasma

  • Delaux, Joakim
  • Nigen, Michaël
  • Fourré, Elodie
  • Tatibouët; Jean-Michel
  • Baraket, Abdellatif
  • Atencio-Genes, Loyda
  • García Fernández, José Manuel
  • Oliveira Vigier, Karine de
  • Jérôme, François
Non-thermal atmospheric plasma (NTAP) is a physical technology that has been previously employed for surface treatment (cleaning, coating, erosion, etc.) and water or air depollution. We show here that, beyond surface effects, NTAP is capable of enabling the complete and fast polymerization of various mono- and disaccharides in the solid state within only a few minutes and at low temperature (40-80 °C). NTAP-induced polymerization involves a radical mechanism and yields water soluble polysaccharides with a mean molar mass of up to 100000 g mol and a mean hydrodynamic radius of 3 nm. Although polymerization reactions promoted by NTAP occurs in a random manner, the α-1,6 and β-1,6 linkages are however dominant. Furthermore, we discovered that NTAP is highly selective, strongly favoring glycosylation over other chemical transformations in the bulk. Under our working conditions, glycosyl units are preserved that constitute the repeating units of the polysaccharide product. No chemical degradation (e.g. intramolecular dehydration reactions) was observed, allowing a white powder to be recovered with a yield higher than 93 wt%. From a practical point of view, NTAP has great potential for breakthrough in the production of polysaccharides, notably because it does not require the use of a solvent or catalyst, thus by-passing the traditional post-treatment of aqueous effluents and catalyst recycling characteristic of biotechnological polysaccharide production. Its efficiency at low temperature also prevents carbohydrates from degradation. Finally, NTAP proceeds on an on/off switch basis, allowing the polymerization reaction to be started and stopped quasi instantaneously., This study was funded by the CNRS, INRA and the French Ministry of Research, including the PhD grant of J. Delaux. This study was also supported by the Spanish Ministerio de Economía y Competitividad (contract numbers SAF2013-44021-R and CTQ2010-15848), the Junta de Andalucía (contract number FQM2012-1467) and the European Regional Development Funds (FEDER and FSE). The authors are grateful to the technical assistance from the research support services of the University of Sevilla (CITIUS), INRA-NANTES and IC2MP. The authors also expressed their sincere thanks to members of the FR CNRS INCREASE 3707 consortium for fruitful discussions and scientific advices.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Revealing cooperative binding of polycationic cyclodextrins with DNA oligomers by capillary electrophoresis coupled to mass spectrometry

  • Przybylski, Cédric
  • Benito, Juan M.
  • Bonnet, Véronique
  • Ortiz-Mellet, Carmen
  • García Fernández, José Manuel
Gene delivery is critical for the development of nucleic acid-based therapies against a range of severe diseases. The conception of non-viral (semi)synthetic vectors with low cytotoxicity and virus-like efficiency is gathering a lot of efforts, but it represents a fantastic challenge still far from accomplishment. Carbohydrate-based scaffolds offer interesting features towards this end, such as easy availability, relatively cheap cost, tuning properties and a good biocompatibility. The lack of analytical methods providing quantitative and qualitative data on their binding properties with oligonucleotides (DNA/RNA), with a minimal time and sample consumption, represents a limitation for these channels. Here, we attempted to fill the gap by hyphenation of capillary electrophoresis with mass spectrometry (CE-MS). This coupling strategy allows discriminating free and complexed DNA oligomers with cationic cyclodextrins (CDs), determining the stoichiometry where the highest observed is always DNA: n/3(CD), and unambiguously assigning the partners through m/z detection. Very reliable data were obtained with migration time within 5.5 (standard deviation < 0.5%) and 25 min (standard deviation < 1.1%) for UV and MS detection, respectively. Furthermore, varying the nitrogen/phosphorus ratio (N/P), key parameters relating to the thermodynamics e.g. the micro and macroscopic dissociation constants K and K, respectively (both in low μM range) and the Gibbs free energy ΔG (−16.3 to −26.9 kJ mol), and also the cooperativity as Hill number (nH between 0.98 and 15.75) of the supramolecular process can be delineated, providing a unique tool for the high throughput screening and selection of efficient gene delivery carriers., The authors thank Genopole-France and the Conseil Régional d’Ile-de-France and the Spanish Ministerio de Economia y Competitividad (MinECo, contract no. SAF2013-44021-R and CTQ2015-64425-C2-1-R).